Lyme Disease DNA Testing
Milford Molecular Diagnostics is the first, and at present, the only licensed clinical laboratory in the United States to offer a combined DNA Sequencing-based diagnostic test for Borrelia burgdorferi, the infectious agent for Lyme disease and Borrelia miyamotoi, the infectious agent of a similar Lyme disease-like illness found recently in the United States.
Milford Molecular Diagnostics can produce a diagnosis within five days of a sample's receipt, ensuring the fastest, most conclusive test for Lyme disease available anywhere. The diagnosis fee is $150.00 per sample.
All tested samples are issued an official laboratory report as well as an accompanying DNA sequencing electropherogram and GenBank BLAST alignment analysis if the result is positive.